Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

Stryker's Endoscopy division acquires Ivy Sports Medicine

Stryker
Posted on: 01 Sep 16

PR Newswire

KALAMAZOO, Michigan, USA, Sept. 1, 2016

KALAMAZOO, Michigan, USA, Sept. 1, 2016 /PRNewswire/ -- Stryker's Endoscopy division announced today it has acquired Ivy Sports Medicine, LLC, whose portfolio is comprised of a comprehensive minimally invasive meniscal repair platform. The addition of Ivy Sports Medicine's portfolio enables Stryker to provide customers with a complete meniscal platform to better serve their patients. 

The portfolio includes the only FDA-approved collagen meniscus implant (CMI®) on the market, a reliable and innovative all-inside repair device, as well as an inside-out meniscal suturing platform.  Ivy's history and sole focus on advancing the treatment of meniscal injuries is also highly complementary to Stryker's current portfolio of visualization, resection, fluid management, and ACL reconstruction platforms. 

"The acquisition of Ivy Sports Medicine strengthens our capabilities and fits strategically with our current portfolio. Ivy's complete meniscal platform, coupled with their clinical history, will allow us to provide our customers with multiple solutions to address meniscal repair," said Matt Moreau, Vice President and General Manager of Stryker's Sports Medicine business.  "This is an area of sports medicine where there is continued opportunity to address unmet customer needs. The Ivy portfolio provides a unique platform for us to build upon as we seek to continue advancing the treatment of meniscal injuries."

"Ivy Sports Medicine was formed to capitalize on the unmet opportunity in meniscal repair, which we view as one of the more attractive growth opportunities in all of orthopaedics," said Robert Pangia, CEO of Ivy Sports Medicine. "Our products provide surgeons with a complete set of tools to treat a large spectrum of meniscal repairs. We are excited about the prospects of combining these products with Stryker's distribution channels and complementary portfolio of sports medicine products."

About Stryker

Stryker is one of the world's leading medical technology companies and, together with our customers, we are driven to make healthcare better. The Company offers a diverse array of innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes. Stryker is active in over 100 countries around the world. Please contact us for more information at www.stryker.com.

Media Contact 
Jenny Braga, Senior Communications Manager 
jenny.braga@stryker.com

Logo - http://photos.prnewswire.com/prnh/20140106/PH40722LOGO

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/strykers-endoscopy-division-acquires-ivy-sports-medicine-300321449.html

SOURCE Stryker

PR Newswire
www.prnewswire.com

Last updated on: 01/09/2016

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.